Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2015 / Cilt: 61 - Sayı: 4

Kalça Kırığı olan Hastalar Kırıktan Önceki Gün Değerlendirilseydi FRAX® Yüksek Riski Tanımlayabilecek Miydi?

Would FRAX Define the High Fracture Risk if the Patients Were Evaluated the Day before Hip Fracture?

Pages
339–343
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were significant differences between the age groups according to the 10-year major osteoporotic and hip fracture probability and fall frequency (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the 10-year major osteoporotic and hip fracture risks in patients with a recent hip fracture.
📊
Key Findings & Data:Material and Methods: The study population comprised 58 patients (32 male and 26 female, mean age 79.1 years) with a recent hip fracture.
💡
Conclusion & Impact:There were significant differences between the age groups according to the 10-year major osteoporotic and hip fracture probability and fall frequency (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the 10-year major osteoporotic and hip fracture risks in patients with a recent hip fracture. Material and Methods: The study population comprised 58 patients (32 male and 26 female, mean age 79.1 years) with a recent hip fracture. A bedside questionnaire including fracture risk assessment tool (FRAX®) variables and fall frequency was administered to the patients. The FRAX® 10-year major osteoporotic and hip fracture risks were calculated. Statistical analyses were performed to compare different age groups (60-69 years, 70-79 years, and >=80 years). Results: The mean 10-year major osteoporotic and hip fracture risks were 13.9% and 78%, respectively. If the National Osteoporosis Foundation guidelines were taken into account according to major osteoporotic and hip fracture risks using FRAX® the day before the fracture, treatment would not be initiated in 75.8% and 18.9% of patients, respectively. There were significant differences between the age groups according to the 10-year major osteoporotic and hip fracture probability and fall frequency (p

Özet

Amaç: Çalışmamızın amacı kalça kırığı geçiren kişilerde 10 yıllık majör osteoporotik ve kalça kırığı risklerini değerlendirmektir. Gereç ve Yöntemler: Çalışmaya yeni kalça kırığı geçiren 58 hasta (32 erkek, 26 kadın, ortalama yaş 79,1 yıl) dahil edildi. Yatak başında uygulanan bir anket ile FRAX® değişkenleri ve düşme sıklığı sorgulandı. FRAX 10 yıllık majör osteoporotik ve kalça kırığı olasılıkları hesaplandı. Farklı yaş gruplarını karşılaştırmak için istatistiksel analiz yapıldı (60-69 yaş, 70-79 yaş ve >= 80 yaş). Bulgular: Ortalama 10 yıllık majör osteoporotik ve kalça kırığı riskleri sırasıyla %13,9 ve %78 olarak bulundu. Eğer FRAX değerleri kırıktan 1 gün önce elde edilmiş olsa idi, National Osteoporosis Foundation kılavuzuna göre değerlendirme yapıldığında, majör osteoporotik kırık riskine göre hastaların %75,8'ine, majör kalça kırığı riskine göre ise hastaların %18,9'una tedavi önerilmeyecekti. Yaş grupları arasında 10 yıllık majör osteoporotik kırık ve kalça kırığı olasılığı ve düşme sıklığına göre anlamlı farklılık saptandı (sırasıyla, p

🔖

Cite This Article

KUYUCU, E., ACAR, M., KOÇYİĞİT, F., BAYDAR, M., KOÇYİĞİT, A. (2022). Kalça Kırığı olan Hastalar Kırıktan Önceki Gün Değerlendirilseydi FRAX® Yüksek Riski Tanımlayabilecek Miydi?. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 61 - Sayı: 4, 339–343. https://ajindex.com/articles/628713

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995:report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24-35. [CrossRef] Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41. [CrossRef] Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004;164:1108-12. [CrossRef] Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, See- man E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004;34:195-202. [CrossRef] Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporosis Int 2008;19:385-97. [CrossRef] Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey EV. FRAX and its applications to clinical practice. Bone 2009;44:734-43. [CrossRef] ElfforIs I, Allander E, Kanis JA, Gullberg B, Johnell O, Dequeker J, et al. The variable incidence of hip fracture in Southern Europe. the MEDOS Study. Osteoporosis Int 1994;4:253-63. [CrossRef] National Osteoporosis Foundation Clinician's guide to prevention and treatment of osteoporosis. Available from: http://nof.org/pro- fessionals/cliniciansguideform.asp. Accessed 22 October 2009.
  2. Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, Baim S, Favus MJ, Kho- sla S, et al. National Osteoporosis Foundation Guide Committee. Im- plications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporosis Int 2008;102:175-9. [CrossRef] Fujiwara S. Utility of Fracture Risk Assesment Tool (FRAX). Nihon Rinsho 2011;69:1239-42. Kanis JA. On behalf of the World Health Organization Scientific Group. Assessmet of osteoporosis at the primary health-care level. Technical report. University of Sheffield, UK: WHO Coolaborating Center. 2008.
  3. Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Senocak M, Johans- son H, et al. Turkish Osteoporosis Society. Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Os- teoporosis Int 2012;23:949-55. [CrossRef] Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort? J Bone Mi